isoproterenol has been researched along with troxerutin in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Araújo, D; Gulati, O; Osswald, W | 1 |
| Bast, A; Beems, DB; de Jong, J; Madhuizen, HT; van Acker, SA; van der Vijgh, WJ; Voest, EE | 1 |
| Chen, D; Feng, C; Zhao, J | 1 |
3 other study(ies) available for isoproterenol and troxerutin
| Article | Year |
|---|---|
Effects of two venotropic drugs on inactivation and O-methylation of catecholamines in an isolated canine vein.
Topics: Animals; Anticoagulants; Catechol O-Methyltransferase Inhibitors; Catecholamines; Dogs; Electric Stimulation; Glucose; Hydroxyethylrutoside; In Vitro Techniques; Isoproterenol; Methylation; Muscle Relaxation; Muscle, Smooth, Vascular; Norepinephrine; Rutin; Saphenous Vein | 1985 |
Cardioprotective properties of O-(beta-hydroxyethyl)-rutosides in doxorubicin-pretreated BALB/c mice.
Topics: Animals; Body Weight; Colforsin; Doxorubicin; Drug Administration Schedule; Free Radical Scavengers; Heart; Heart Rate; Hydroxyethylrutoside; Injections, Intraperitoneal; Injections, Intravenous; Isoproterenol; Male; Mice; Mice, Inbred BALB C; Myocardial Contraction; Myocardium; Razoxane; Time Factors | 1993 |
Troxerutin attenuates isoproterenol-induced cardiac hypertrophy via the LKB1/AMPK/mTOR pathway.
Topics: AMP-Activated Protein Kinases; Animals; Anticoagulants; Cardiomegaly; Hydroxyethylrutoside; Isoproterenol; Rats; TOR Serine-Threonine Kinases | 2021 |